Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hydrocephalus | 63 | 2024 | 768 | 12.740 |
Why?
|
Ventriculostomy | 33 | 2024 | 132 | 8.950 |
Why?
|
Choroid Plexus | 25 | 2024 | 249 | 6.530 |
Why?
|
Third Ventricle | 20 | 2024 | 78 | 6.190 |
Why?
|
Neuroendoscopy | 15 | 2024 | 100 | 6.100 |
Why?
|
Cautery | 18 | 2024 | 73 | 5.220 |
Why?
|
Spinal Dysraphism | 10 | 2024 | 179 | 3.070 |
Why?
|
Meningomyelocele | 11 | 2024 | 182 | 2.670 |
Why?
|
Cerebrospinal Fluid Shunts | 12 | 2024 | 197 | 2.520 |
Why?
|
Uganda | 39 | 2023 | 1361 | 2.410 |
Why?
|
Ventriculoperitoneal Shunt | 12 | 2021 | 186 | 2.020 |
Why?
|
Endoscopy | 11 | 2013 | 1854 | 1.470 |
Why?
|
Neurosurgery | 8 | 2020 | 682 | 1.430 |
Why?
|
Neurosurgical Procedures | 15 | 2024 | 2076 | 1.320 |
Why?
|
Neural Tube Defects | 3 | 2024 | 255 | 1.260 |
Why?
|
Infant | 63 | 2024 | 36535 | 1.100 |
Why?
|
Developing Countries | 13 | 2020 | 2910 | 1.080 |
Why?
|
Cysts | 3 | 2023 | 685 | 1.010 |
Why?
|
Nervous System Malformations | 1 | 2023 | 243 | 0.760 |
Why?
|
Cerebral Aqueduct | 2 | 2012 | 39 | 0.750 |
Why?
|
Cisterna Magna | 2 | 2011 | 39 | 0.720 |
Why?
|
Arsenic | 4 | 2024 | 358 | 0.690 |
Why?
|
Paenibacillus | 3 | 2023 | 16 | 0.620 |
Why?
|
Bacterial Infections | 2 | 2019 | 1397 | 0.600 |
Why?
|
Pediatrics | 4 | 2018 | 3629 | 0.580 |
Why?
|
Electrocoagulation | 2 | 2008 | 156 | 0.560 |
Why?
|
Hyperplasia | 1 | 2020 | 1151 | 0.550 |
Why?
|
Treatment Outcome | 34 | 2024 | 65371 | 0.520 |
Why?
|
Child | 45 | 2024 | 80917 | 0.500 |
Why?
|
Cerebrospinal Fluid | 4 | 2021 | 540 | 0.490 |
Why?
|
Kaplan-Meier Estimate | 11 | 2019 | 6526 | 0.480 |
Why?
|
Lateral Ventricles | 1 | 2016 | 142 | 0.480 |
Why?
|
Anti-Bacterial Agents | 8 | 2024 | 7477 | 0.470 |
Why?
|
Models, Anatomic | 2 | 2014 | 680 | 0.450 |
Why?
|
Manikins | 2 | 2014 | 254 | 0.440 |
Why?
|
Africa South of the Sahara | 6 | 2013 | 752 | 0.420 |
Why?
|
Tropical Climate | 1 | 2012 | 35 | 0.410 |
Why?
|
Child, Preschool | 27 | 2024 | 42669 | 0.410 |
Why?
|
Rain | 1 | 2012 | 60 | 0.400 |
Why?
|
Humans | 116 | 2024 | 768166 | 0.400 |
Why?
|
Dandy-Walker Syndrome | 1 | 2011 | 45 | 0.390 |
Why?
|
Child Development | 3 | 2021 | 2330 | 0.380 |
Why?
|
Folic Acid | 3 | 2024 | 1337 | 0.370 |
Why?
|
Spinal Cord Neoplasms | 2 | 2012 | 263 | 0.370 |
Why?
|
Comprehension | 1 | 2016 | 638 | 0.370 |
Why?
|
Equipment Failure | 4 | 2019 | 585 | 0.360 |
Why?
|
Arnold-Chiari Malformation | 1 | 2012 | 160 | 0.360 |
Why?
|
Meningocele | 2 | 2024 | 50 | 0.360 |
Why?
|
Antibiotic Prophylaxis | 3 | 2024 | 640 | 0.350 |
Why?
|
Infant, Newborn | 27 | 2024 | 26422 | 0.350 |
Why?
|
Death, Sudden | 1 | 2012 | 301 | 0.340 |
Why?
|
Encephalocele | 1 | 2011 | 135 | 0.330 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 1135 | 0.330 |
Why?
|
Brain Diseases | 4 | 2012 | 1554 | 0.330 |
Why?
|
Postoperative Complications | 6 | 2021 | 15832 | 0.330 |
Why?
|
Male | 61 | 2024 | 364719 | 0.330 |
Why?
|
Cerebral Ventricles | 3 | 2020 | 550 | 0.310 |
Why?
|
Rhizotomy | 2 | 2000 | 30 | 0.310 |
Why?
|
Female | 62 | 2024 | 397192 | 0.310 |
Why?
|
Meningitis | 2 | 2023 | 219 | 0.300 |
Why?
|
User-Computer Interface | 1 | 2014 | 1407 | 0.300 |
Why?
|
Quality of Life | 3 | 2018 | 13490 | 0.290 |
Why?
|
Bangladesh | 6 | 2024 | 742 | 0.280 |
Why?
|
Altruism | 1 | 2009 | 211 | 0.280 |
Why?
|
Muscle Spasticity | 2 | 2000 | 159 | 0.280 |
Why?
|
Anus, Imperforate | 2 | 2020 | 63 | 0.280 |
Why?
|
Seizures | 2 | 2019 | 2998 | 0.280 |
Why?
|
Seasons | 2 | 2012 | 1524 | 0.280 |
Why?
|
Cavernous Sinus | 2 | 1999 | 121 | 0.270 |
Why?
|
Biomedical Research | 3 | 2017 | 3463 | 0.270 |
Why?
|
Public Health | 1 | 2020 | 2679 | 0.270 |
Why?
|
Nervous System | 1 | 2009 | 544 | 0.270 |
Why?
|
Disease Management | 1 | 2016 | 2536 | 0.250 |
Why?
|
Ganglia, Spinal | 2 | 2000 | 529 | 0.250 |
Why?
|
Health Services Accessibility | 3 | 2018 | 5520 | 0.240 |
Why?
|
Egypt | 1 | 2024 | 100 | 0.240 |
Why?
|
Magnetic Resonance Imaging | 20 | 2024 | 36743 | 0.240 |
Why?
|
Spina Bifida Occulta | 2 | 1995 | 31 | 0.240 |
Why?
|
Health Policy | 1 | 2017 | 2698 | 0.230 |
Why?
|
Urogenital Abnormalities | 2 | 2020 | 255 | 0.230 |
Why?
|
Follow-Up Studies | 14 | 2019 | 39348 | 0.230 |
Why?
|
Hospitals, Pediatric | 1 | 2013 | 1876 | 0.230 |
Why?
|
Health Services | 1 | 2009 | 755 | 0.230 |
Why?
|
Computer Simulation | 2 | 2014 | 6283 | 0.230 |
Why?
|
Internship and Residency | 5 | 2017 | 5953 | 0.230 |
Why?
|
Coagulase | 1 | 2023 | 53 | 0.220 |
Why?
|
Cerebral Palsy | 2 | 2000 | 480 | 0.220 |
Why?
|
Spinal Cord | 4 | 2023 | 1811 | 0.210 |
Why?
|
Epilepsy | 2 | 2016 | 3327 | 0.210 |
Why?
|
Cognition | 4 | 2017 | 7073 | 0.210 |
Why?
|
Retrospective Studies | 18 | 2024 | 81762 | 0.210 |
Why?
|
Surgical Wound Infection | 4 | 2024 | 1546 | 0.210 |
Why?
|
Sepsis | 3 | 2023 | 2608 | 0.200 |
Why?
|
Subdural Effusion | 1 | 2021 | 19 | 0.200 |
Why?
|
Population | 2 | 2021 | 141 | 0.190 |
Why?
|
Prospective Studies | 10 | 2024 | 54926 | 0.190 |
Why?
|
Africa, Eastern | 2 | 2012 | 76 | 0.190 |
Why?
|
Brain | 9 | 2024 | 27360 | 0.190 |
Why?
|
Adolescent | 18 | 2024 | 89169 | 0.190 |
Why?
|
Cerebral Hemorrhage | 4 | 2023 | 2655 | 0.190 |
Why?
|
Tetraploidy | 1 | 2020 | 28 | 0.180 |
Why?
|
Judgment | 2 | 1999 | 273 | 0.180 |
Why?
|
Maternal Exposure | 2 | 2024 | 1096 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 11 | 2021 | 20760 | 0.170 |
Why?
|
Scoliosis | 2 | 2020 | 793 | 0.170 |
Why?
|
Hernia, Umbilical | 1 | 2020 | 102 | 0.160 |
Why?
|
Faculty | 2 | 1999 | 383 | 0.160 |
Why?
|
Neuroendoscopes | 2 | 2017 | 7 | 0.160 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2019 | 62 | 0.160 |
Why?
|
Organ Size | 5 | 2021 | 2267 | 0.160 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2020 | 534 | 0.150 |
Why?
|
Brain Neoplasms | 4 | 2013 | 9118 | 0.150 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 2014 | 390 | 0.150 |
Why?
|
Cohort Studies | 9 | 2021 | 41754 | 0.150 |
Why?
|
Clinical Competence | 3 | 2014 | 4858 | 0.150 |
Why?
|
Reoperation | 3 | 2015 | 4329 | 0.150 |
Why?
|
Child Language | 1 | 2017 | 62 | 0.140 |
Why?
|
Vascular Neoplasms | 1 | 1999 | 167 | 0.140 |
Why?
|
Cervical Vertebrae | 2 | 2012 | 979 | 0.140 |
Why?
|
Treatment Failure | 3 | 2012 | 2661 | 0.140 |
Why?
|
Syndrome | 1 | 2023 | 3272 | 0.140 |
Why?
|
Nigeria | 1 | 2020 | 781 | 0.140 |
Why?
|
Catheters | 3 | 2024 | 427 | 0.130 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12543 | 0.130 |
Why?
|
Intracranial Hypertension | 1 | 2019 | 191 | 0.130 |
Why?
|
Age Factors | 5 | 2012 | 18412 | 0.130 |
Why?
|
Encephalitis | 1 | 2020 | 441 | 0.130 |
Why?
|
Cerebral Ventriculitis | 1 | 2015 | 7 | 0.130 |
Why?
|
Teratoma | 1 | 1999 | 405 | 0.130 |
Why?
|
History, 21st Century | 2 | 2014 | 1573 | 0.130 |
Why?
|
Models, Educational | 1 | 2018 | 375 | 0.130 |
Why?
|
Meningitis, Aseptic | 1 | 1995 | 59 | 0.120 |
Why?
|
Arachnoid | 1 | 2015 | 50 | 0.120 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 1996 | 111 | 0.120 |
Why?
|
Electromyography | 2 | 2000 | 1401 | 0.120 |
Why?
|
Health Resources | 2 | 2018 | 950 | 0.120 |
Why?
|
Epidermal Cyst | 1 | 1995 | 63 | 0.120 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2014 | 46 | 0.120 |
Why?
|
Dermoid Cyst | 1 | 1995 | 92 | 0.120 |
Why?
|
Motor Skills | 1 | 2017 | 523 | 0.120 |
Why?
|
Neural Stem Cells | 2 | 2020 | 895 | 0.120 |
Why?
|
Infant, Premature, Diseases | 1 | 2020 | 712 | 0.120 |
Why?
|
Time Factors | 6 | 2016 | 40218 | 0.110 |
Why?
|
Fourth Ventricle | 2 | 2011 | 32 | 0.110 |
Why?
|
Neuroanatomy | 1 | 2014 | 73 | 0.110 |
Why?
|
Neurogenesis | 1 | 2020 | 864 | 0.110 |
Why?
|
Survival Rate | 4 | 2024 | 12840 | 0.110 |
Why?
|
History, 20th Century | 2 | 2014 | 2766 | 0.110 |
Why?
|
Functional Laterality | 2 | 2021 | 2264 | 0.110 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2014 | 459 | 0.110 |
Why?
|
Incidence | 4 | 2021 | 21538 | 0.110 |
Why?
|
Injections, Spinal | 2 | 2024 | 317 | 0.110 |
Why?
|
Fibromatosis, Aggressive | 1 | 1994 | 125 | 0.110 |
Why?
|
Vascular Malformations | 1 | 2019 | 469 | 0.110 |
Why?
|
Meningitis, Bacterial | 1 | 1995 | 225 | 0.110 |
Why?
|
Cloaca | 1 | 1993 | 52 | 0.100 |
Why?
|
Interpersonal Relations | 1 | 1999 | 1434 | 0.100 |
Why?
|
Rhombencephalon | 1 | 2012 | 81 | 0.100 |
Why?
|
Catheters, Indwelling | 2 | 2024 | 436 | 0.100 |
Why?
|
Case-Control Studies | 6 | 2024 | 22291 | 0.090 |
Why?
|
Fetal Diseases | 2 | 2013 | 916 | 0.090 |
Why?
|
General Surgery | 2 | 1999 | 1720 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2014 | 15454 | 0.090 |
Why?
|
Catheter-Related Infections | 2 | 2024 | 275 | 0.090 |
Why?
|
Sleep Apnea, Central | 1 | 2012 | 88 | 0.090 |
Why?
|
North America | 1 | 2014 | 1289 | 0.090 |
Why?
|
Obstetrics | 1 | 2017 | 681 | 0.090 |
Why?
|
Ependyma | 1 | 1990 | 57 | 0.090 |
Why?
|
Spinal Diseases | 1 | 1995 | 561 | 0.090 |
Why?
|
DNA Methylation | 1 | 2024 | 4428 | 0.090 |
Why?
|
Craniosynostoses | 1 | 2014 | 415 | 0.090 |
Why?
|
Mesencephalon | 1 | 2012 | 338 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 1996 | 948 | 0.080 |
Why?
|
Central America | 1 | 2009 | 69 | 0.080 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 5536 | 0.080 |
Why?
|
Survival Analysis | 2 | 2013 | 10101 | 0.080 |
Why?
|
South America | 1 | 2009 | 180 | 0.080 |
Why?
|
Mobile Health Units | 1 | 2010 | 93 | 0.080 |
Why?
|
Gram-Negative Bacteria | 1 | 2011 | 275 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2021 | 6229 | 0.080 |
Why?
|
Guatemala | 1 | 2009 | 161 | 0.080 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2011 | 238 | 0.080 |
Why?
|
Risk Factors | 7 | 2021 | 74944 | 0.080 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 1104 | 0.080 |
Why?
|
Spinal Neoplasms | 1 | 1994 | 715 | 0.070 |
Why?
|
Infant, Newborn, Diseases | 1 | 2013 | 587 | 0.070 |
Why?
|
Africa | 1 | 2010 | 725 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2017 | 3390 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2945 | 0.070 |
Why?
|
Oligodendroglia | 1 | 1991 | 540 | 0.070 |
Why?
|
Young Adult | 7 | 2024 | 60066 | 0.070 |
Why?
|
Medical Records | 1 | 2012 | 1410 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2011 | 1049 | 0.070 |
Why?
|
Capacity Building | 2 | 2020 | 265 | 0.070 |
Why?
|
Neuropsychological Tests | 2 | 2017 | 7140 | 0.070 |
Why?
|
Neurology | 1 | 2014 | 786 | 0.070 |
Why?
|
Patient Selection | 2 | 2011 | 4260 | 0.070 |
Why?
|
Population Surveillance | 1 | 2017 | 2596 | 0.070 |
Why?
|
Anesthesia | 1 | 2017 | 1596 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18065 | 0.070 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2013 | 1354 | 0.070 |
Why?
|
Respiratory Tract Diseases | 1 | 2012 | 744 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1932 | 0.060 |
Why?
|
DNA, Bacterial | 1 | 2011 | 1478 | 0.060 |
Why?
|
Sex Distribution | 1 | 2011 | 2278 | 0.060 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 2000 | 0.060 |
Why?
|
Brain Stem | 1 | 1990 | 859 | 0.060 |
Why?
|
Quality-Adjusted Life Years | 1 | 2011 | 1741 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 16045 | 0.060 |
Why?
|
Postoperative Period | 1 | 2009 | 1826 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2517 | 0.060 |
Why?
|
Odds Ratio | 2 | 2017 | 9669 | 0.060 |
Why?
|
Pregnancy | 6 | 2024 | 30256 | 0.060 |
Why?
|
Disability Evaluation | 1 | 2011 | 1835 | 0.060 |
Why?
|
Heart Diseases | 2 | 2020 | 2819 | 0.060 |
Why?
|
Curriculum | 2 | 2014 | 3782 | 0.060 |
Why?
|
Paternal Exposure | 1 | 2024 | 100 | 0.060 |
Why?
|
Algorithms | 4 | 2021 | 14164 | 0.050 |
Why?
|
Gentamicins | 1 | 2024 | 244 | 0.050 |
Why?
|
Surgical Flaps | 1 | 2012 | 1682 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2012 | 8542 | 0.050 |
Why?
|
Occipital Lobe | 2 | 2014 | 376 | 0.050 |
Why?
|
Nails | 1 | 2024 | 298 | 0.050 |
Why?
|
Bacteria | 1 | 2013 | 2216 | 0.050 |
Why?
|
Rifampin | 1 | 2024 | 352 | 0.050 |
Why?
|
Zambia | 1 | 2022 | 273 | 0.050 |
Why?
|
Subarachnoid Hemorrhage | 1 | 1989 | 1024 | 0.050 |
Why?
|
Cost of Illness | 1 | 2011 | 1951 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1662 | 0.050 |
Why?
|
Infant, Premature | 1 | 2011 | 2124 | 0.050 |
Why?
|
Vancomycin | 1 | 2024 | 506 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2012 | 2100 | 0.050 |
Why?
|
Mothers | 1 | 2011 | 2209 | 0.050 |
Why?
|
Cause of Death | 1 | 2011 | 3721 | 0.050 |
Why?
|
Clindamycin | 1 | 2021 | 138 | 0.040 |
Why?
|
Injections, Intraventricular | 1 | 2021 | 227 | 0.040 |
Why?
|
Pilot Projects | 2 | 2011 | 8741 | 0.040 |
Why?
|
Regression Analysis | 1 | 2010 | 6340 | 0.040 |
Why?
|
Water Pollutants, Chemical | 1 | 2024 | 359 | 0.040 |
Why?
|
Pre-Eclampsia | 1 | 1989 | 1255 | 0.040 |
Why?
|
Reflex, Abnormal | 1 | 2000 | 83 | 0.040 |
Why?
|
CpG Islands | 1 | 2024 | 1208 | 0.040 |
Why?
|
United States | 4 | 2024 | 73039 | 0.040 |
Why?
|
Recurrence | 2 | 2007 | 8509 | 0.040 |
Why?
|
Twins, Conjoined | 1 | 1999 | 41 | 0.040 |
Why?
|
Sciatica | 1 | 1999 | 97 | 0.040 |
Why?
|
Dilatation | 1 | 2020 | 311 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 1996 | 13014 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2021 | 323 | 0.040 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2024 | 752 | 0.040 |
Why?
|
Stem Cells | 1 | 1991 | 3537 | 0.040 |
Why?
|
Frontal Lobe | 2 | 2014 | 1426 | 0.040 |
Why?
|
Sex Factors | 1 | 2012 | 10632 | 0.040 |
Why?
|
Craniotomy | 2 | 2014 | 736 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1014 | 0.040 |
Why?
|
Growth Charts | 1 | 2018 | 60 | 0.040 |
Why?
|
Mutation | 2 | 2020 | 30238 | 0.040 |
Why?
|
Sphenoid Sinusitis | 1 | 1996 | 10 | 0.030 |
Why?
|
Ultrasonography | 3 | 1996 | 6004 | 0.030 |
Why?
|
Prognosis | 2 | 2010 | 30010 | 0.030 |
Why?
|
Anthropometry | 1 | 2021 | 1346 | 0.030 |
Why?
|
Haiti | 1 | 2018 | 553 | 0.030 |
Why?
|
Spinal Nerve Roots | 1 | 1996 | 122 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20227 | 0.030 |
Why?
|
Biostatistics | 1 | 2018 | 163 | 0.030 |
Why?
|
Neurologic Examination | 1 | 1999 | 914 | 0.030 |
Why?
|
Head | 1 | 2022 | 926 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26379 | 0.030 |
Why?
|
Dependovirus | 1 | 2021 | 720 | 0.030 |
Why?
|
Animals | 6 | 2021 | 169246 | 0.030 |
Why?
|
Research Design | 1 | 2011 | 6211 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2021 | 2678 | 0.030 |
Why?
|
Models, Statistical | 1 | 2010 | 5107 | 0.030 |
Why?
|
Adult | 6 | 2024 | 223646 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2021 | 1676 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 960 | 0.030 |
Why?
|
Neurotoxins | 1 | 2015 | 240 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 1232 | 0.030 |
Why?
|
Gait | 1 | 2000 | 823 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1329 | 0.030 |
Why?
|
Body Mass Index | 1 | 2012 | 13053 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1725 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2015 | 353 | 0.030 |
Why?
|
Reaction Time | 1 | 2000 | 2101 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 2020 | 1424 | 0.030 |
Why?
|
Evoked Potentials, Motor | 1 | 1996 | 465 | 0.030 |
Why?
|
Colony Count, Microbial | 1 | 2013 | 328 | 0.030 |
Why?
|
Prevalence | 1 | 2010 | 15869 | 0.030 |
Why?
|
Urogenital System | 1 | 1993 | 88 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2234 | 0.030 |
Why?
|
Goals | 1 | 2017 | 717 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1429 | 0.020 |
Why?
|
Vision Disorders | 1 | 1999 | 1093 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2021 | 3402 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1892 | 0.020 |
Why?
|
Electric Stimulation | 1 | 1996 | 1741 | 0.020 |
Why?
|
Motor Neurons | 1 | 1996 | 870 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3833 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 1901 | 0.020 |
Why?
|
Proteobacteria | 1 | 2011 | 47 | 0.020 |
Why?
|
Sacrum | 1 | 1993 | 274 | 0.020 |
Why?
|
Cicatrix | 1 | 2017 | 798 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2650 | 0.020 |
Why?
|
Lipoma | 1 | 1993 | 296 | 0.020 |
Why?
|
Embryonic and Fetal Development | 1 | 1991 | 420 | 0.020 |
Why?
|
Body Weight | 1 | 2021 | 4627 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4539 | 0.020 |
Why?
|
Lung Diseases | 1 | 2020 | 1944 | 0.020 |
Why?
|
Subarachnoid Space | 1 | 1990 | 79 | 0.020 |
Why?
|
Transcription Factors | 2 | 2020 | 12168 | 0.020 |
Why?
|
Cytological Techniques | 1 | 1991 | 217 | 0.020 |
Why?
|
Malnutrition | 1 | 2015 | 632 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1969 | 0.020 |
Why?
|
Spine | 1 | 1995 | 1140 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9561 | 0.020 |
Why?
|
Israel | 1 | 2010 | 726 | 0.020 |
Why?
|
Pinealoma | 1 | 2008 | 52 | 0.020 |
Why?
|
Optic Chiasm | 1 | 2008 | 91 | 0.020 |
Why?
|
Optic Nerve Neoplasms | 1 | 2008 | 45 | 0.020 |
Why?
|
Central Nervous System Cysts | 1 | 2008 | 56 | 0.020 |
Why?
|
Rural Population | 1 | 2018 | 2325 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 3212 | 0.020 |
Why?
|
Developed Countries | 1 | 2010 | 451 | 0.020 |
Why?
|
Hypothalamic Diseases | 1 | 2008 | 134 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6498 | 0.020 |
Why?
|
Neurocysticercosis | 1 | 2008 | 91 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13671 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 1999 | 12077 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10590 | 0.020 |
Why?
|
Malaria | 1 | 2015 | 1249 | 0.020 |
Why?
|
Hamartoma | 1 | 2008 | 236 | 0.020 |
Why?
|
Counseling | 1 | 2013 | 1554 | 0.020 |
Why?
|
Craniopharyngioma | 1 | 2008 | 279 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9015 | 0.010 |
Why?
|
Canada | 1 | 2010 | 2130 | 0.010 |
Why?
|
Radiography | 1 | 1995 | 6983 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 1989 | 1264 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2020 | 4712 | 0.010 |
Why?
|
Mice | 2 | 2021 | 82029 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1990 | 1275 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10099 | 0.010 |
Why?
|
Zinostatin | 1 | 1981 | 7 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9495 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6082 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18349 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1996 | 4978 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4063 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2809 | 0.010 |
Why?
|
Cesarean Section | 1 | 1989 | 1425 | 0.010 |
Why?
|
Parents | 1 | 2013 | 3595 | 0.010 |
Why?
|
Cell Movement | 1 | 1991 | 5210 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 2008 | 1322 | 0.010 |
Why?
|
Aging | 1 | 2018 | 8744 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9613 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1981 | 681 | 0.010 |
Why?
|
Cell Line | 1 | 1991 | 15597 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15662 | 0.010 |
Why?
|
Rats | 1 | 1991 | 23760 | 0.010 |
Why?
|
DNA, Viral | 1 | 1981 | 2204 | 0.010 |
Why?
|
Cell Differentiation | 1 | 1991 | 11669 | 0.010 |
Why?
|
Electroencephalography | 1 | 2009 | 6314 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59629 | 0.010 |
Why?
|
Glioma | 1 | 2008 | 3503 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1991 | 9419 | 0.010 |
Why?
|
Middle Aged | 2 | 2018 | 223492 | 0.010 |
Why?
|
HIV Infections | 1 | 2015 | 17569 | 0.000 |
Why?
|
Aged | 1 | 2018 | 171504 | 0.000 |
Why?
|
Ethidium | 1 | 1981 | 27 | 0.000 |
Why?
|
Mercaptoethanol | 1 | 1981 | 61 | 0.000 |
Why?
|
Chemistry | 1 | 1981 | 327 | 0.000 |
Why?
|
Nucleic Acid Denaturation | 1 | 1981 | 111 | 0.000 |
Why?
|
Chemical Phenomena | 1 | 1981 | 486 | 0.000 |
Why?
|
Pseudomonas | 1 | 1981 | 124 | 0.000 |
Why?
|
Bacteriophages | 1 | 1981 | 382 | 0.000 |
Why?
|
Nucleic Acid Conformation | 1 | 1981 | 899 | 0.000 |
Why?
|